Company / CIK 0001818382
Humacyte, Inc.
- Ticker
- HUMA
- Size, estimated from filings
- Micro cap (under $300M)
- Insiders on file
- 9
- Members of Congress who traded it
- 1
- Federal contracts on record
- none matched
- Lobbying filings on record
- 7
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 6, 2026
Humacyte, Inc. (HUMA) has 9 insiders on file who disclosed 12 transactions in the last 12 months (3 open-market buys, 0 sales, about $30K at reported prices), and 5 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 3 lobbying filings naming it as client report $150K in 2026.
Humacyte, Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
1 person accounts for the disclosed buying and selling in Humacyte, Inc. over the last 12 months; the most active is Jones Keith Anthony with $30K.
Lobbying spend by quarter
How much has Humacyte, Inc. reported spending on federal lobbying?
Humacyte, Inc. reported $250K in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| COWARD D SCOTT | Director | 1 | 0 | 0 | October 7, 2026 |
| Kuznik Paul Brian | Director | 1 | 0 | 0 | October 7, 2026 |
| Jones Keith Anthony | Director | 4 | 3 | 0 | September 15, 2026 |
| Windham-Bannister Susan Richards | Director | 1 | 0 | 0 | June 12, 2026 |
| Constantino Michael T. | Director | 1 | 0 | 0 | June 12, 2026 |
| Wallace Max N. | Director | 1 | 0 | 0 | June 12, 2026 |
| Niklason Laura E | President, CEO and Director | 1 | 0 | 0 | June 12, 2026 |
| Sebelius Kathleen | Director | 1 | 0 | 0 | June 12, 2026 |
| Green Charles Bruce | Director | 1 | 0 | 0 | June 12, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded HUMA
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the HUMA page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Tommy Tuberville | Senator (AL), Republican | 5 | 3 | 2 | $33K–$145K | May 3, 2024 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kuznik Paul Brian | HUMA | Other A | October 6, 2026 | October 7, 2026 | 1d | 125,000 | — | — | derivative | Form 4 ↗ | |
| COWARD D SCOTT | HUMA | Other A | October 6, 2026 | October 7, 2026 | 1d | 125,000 | — | — | derivative | Form 4 ↗ | |
| Jones Keith Anthony | HUMA | Buy P | September 14, 2026 | September 15, 2026 | 1d | 10,000 | $1 | $5,620 | Form 4 ↗ | ||
| Jones Keith Anthony | HUMA | Buy P | August 20, 2026 | August 21, 2026 | 1d | 10,000 | $1 | $6,930 | Form 4 ↗ | ||
| Jones Keith Anthony | HUMA | Buy P | August 17, 2026 | August 19, 2026 | 2d | 30,000 | $1 | $18K | Form 4 ↗ | ||
| Green Charles Bruce | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | derivative | Form 4 ↗ | |
| Jones Keith Anthony | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | derivative | Form 4 ↗ | |
| Sebelius Kathleen | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | derivative | Form 4 ↗ | |
| Niklason Laura E | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | indirectderivative | Form 4 ↗ | |
| Wallace Max N. | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | derivative | Form 4 ↗ | |
| Constantino Michael T. | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | derivative | Form 4 ↗ | |
| Windham-Bannister Susan Richards | HUMA | Other A | June 11, 2026 | June 12, 2026 | 1d | 80,000 | — | — | derivative | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "Humacyte, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $50,000 | LDA ↗ |
| 2026 Q2 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $50,000 | LDA ↗ |
| 2026 Q1 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $50,000 | LDA ↗ |
| 2025 Q4 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $50,000 | LDA ↗ |
| 2025 Q3 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $50,000 | LDA ↗ |
| 2025 Q3 | CAPITOL HILL CONSULTING GROUP | Health Issues | — | LDA ↗ |
| 2025 Q3 | G2G CONSULTING | Health Issues | — | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded HUMA, by number of filers in common. It shows overlap in public filings and nothing else.
- HERSHEY CO HSY 1 filer in common
- NETFLIX INC NFLX 1 filer in common
- ADOBE INC. ADBE 1 filer in common
- ELI LILLY & Co LLY 1 filer in common
- Accenture plc ACN 1 filer in common
- CHEVRON CORP CVX 1 filer in common
- MONOLITHIC POWER SYSTEMS INC MPWR 1 filer in common
- CINTAS CORP CTAS 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| Senate eFD, periodic transaction reports | 2 | 5 | August 5, 2026 | August 5, 2026 | Senate eFD search |
| SEC EDGAR, Form 4 | 12 | 12 | June 12, 2026 | October 7, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 7 filings | — | — | — | LDA.gov search |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.